This study evaluates the safety and efficacy simultaneous, trans-conjunctival, 25-Gauge vitrectomy and phacoemulsification with intraocular lens implant in patients with metamorphopsia and visual impairment due to idiopathic epiretinal membrane and cataract. All 30 patients recruited underwent complete ocular examination, visual acuity measurement with ETDRS, metamorphopsia assessment with M-Charts and Metamorphometry® and foveal thickness evaluation by sd-OCT preoperatively, at 30, 90, 180 days postoperatively.
Study Type
OBSERVATIONAL
Enrollment
30
Cataract extraction, intraocular lens implant, vitrectomy, epiretinal membrane and inner limiting retinal membrane peeling.
Metamorphopsia
Change in spatial degree of distortion perception
Time frame: Change in metamorphopsia from baseline at 180 days.
Visual Acuity
Change in LogMAR visual acuity
Time frame: Change in visual acuity from baseline at 180 days
Area of central scotoma
Change in area, in square pixel, of central scotoma
Time frame: Change in area of central scotoma from baseline at 180 days
Central fovea thickness
Change in fovea thickness in µm at the Sd OCT
Time frame: Change in fovea thickness from baseline at 180 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.